🏠 HOME
💸 MONEY
🎯 SUCCESS
🧠 Brain 🌍 Travel Archive 🚀 Space Archive 🎙️ Podcasts 📺 Video Archive 🎥 Crime & Movies
  • Skip to main content

Mad Mad News

LIVE ABOVE THE MADNESS

Order Now • Check Delivery Today
As an Amazon Associate I earn from qualifying purchases. Delivery availability varies by item and location.

The Street

Your health insurer may already own your doctor’s office

September 10, 2026 MMN Editor Filed Under: Uncategorized

Patients expect their physicians to recommend treatments based on medical evidence. But a growing body of university research suggests that the company covering the insurance may also employ the doctor diagnosing and treating the patient’s conditions.

Five of the largest health insurance companies in the United States now operate networks of physician practices, pharmacy benefit managers, and ambulatory surgery centers. 

Those five insurers collectively cover about 126 million Americans and control 69% of all Medicare Advantage enrollment, a Brookings Institution analysis found.

For the millions of people comparing plans during the next open enrollment window, the financial relationship between insurers and physicians is invisible, yet consequential. 

New data from Brown University and Brookings show that when insurers buy doctor practices, spending climbs.

UnitedHealth’s Optum acquisitions added $250 million in annual Medicare spending

A working paper from Brown University’s Center for Advancing Health Policy through Research measured what happened after UnitedHealth Group purchased physician practices through Optum.

The research team tracked more than 200 acquired practices and followed about 4,500 primary care providers alongside more than 500,000 Medicare patients. 

Medicare Advantage payments tied to those practices rose by roughly $250 million per year after the acquisitions, the Brown researchers concluded.

That increase in spending produced no measurable improvement in patient care quality. Patients at the acquired practices were no less likely to be hospitalized or visit the emergency room, two standard measures used to evaluate clinical performance.

“The rise of insurers, particularly UnitedHealth, acquiring physician practices is one of the most notable recent trends in health care consolidation,” said Jeffrey Marr, Brown’s assistant professor of health services, policy, and practice. 

Marr added that regulators including the Department of Justice and Congress have scrutinized the practice, yet little empirical evidence exists to show whether the deals benefit patients.

Acquired practices listed more diagnoses without treating sicker patients

After UnitedHealth completed the acquisitions, physicians at the purchased practices began documenting more medical conditions per patient during routine visits.

That pattern made patients appear sicker in billing records, according to a press release on the Brown working paper.

In Medicare Advantage, insurers receive larger federal payments for patients documented with more serious or numerous conditions.

More Healthcare/Health:

One IRA withdrawal can triple your Medicare premium

UnitedHealth’s earnings comeback hides a risk Wall Street can’t price

Medicare’s new $50 GLP-1 deal has a catch

“It’s primarily known as a way of gaming the system,” said Christopher Whaley, associate director of the Center for Advancing Health Policy through Research, in the press release. 

“The main point of this gaming is that it substantially increases payment to insurers, in this case, UnitedHealthcare, even though the patient’s true conditions remain the same,” he said.

Medicare Advantage now covers more than half of all Medicare beneficiaries, and federal payments to Medicare Advantage plans reached $534 billion in 2025, according to the Medicare Trustees Report. 

In 2022 alone, the acquired practices generated about $265 million in additional Medicare Advantage payments tied to the diagnostic coding changes.

Acquired practices recorded more diagnoses, making patients appear sicker and driving higher Medicare Advantage payments without changes in their health.Me 3645 Studio / Getty Images

UnitedHealthcare paid Optum doctors up to 61% more in concentrated markets

A study published in Health Affairs by researchers at Brown and the University of California at Berkeley examined how UnitedHealthcare compensates physicians.

Using newly available federal price transparency data, the team found that UnitedHealthcare pays Optum doctors about 17% more than independent practices for identical services. 

In markets where UnitedHealthcare controls a large share of the insurance business, that payment difference widened to as much as 61%, the study found.

Daniel Arnold, the study’s lead author and a senior research scientist at Brown’s School of Public Health, said in a Brown release that the payment pattern only makes financial sense once the corporate structure is factored in.

What we saw in the data was that UnitedHealthcare is paying its doctor practices at Optum well above the market rate. Normally, an insurance company wouldn’t pay above market rate because it costs them money, but here it’s not really a cost.

Federal law requires insurers to spend between 80% and 85% of collected premiums on medical care, depending on market segment, under a rule known as the Medical Loss Ratio. Medicare Advantage plans, the focus of the Brown research, are subject to the 85% threshold.

By directing higher payments to their physician networks, insurers can meet the Medical Loss Ratio threshold on paper without reducing overall corporate revenue.

Nearly 80% of U.S. physicians now work for corporate owners, and Congress is responding

That financial architecture gives insurers a structural reason to continue acquiring physician practices, and the ownership shift is already well advanced.

By 2024, nearly 80% of physicians in the United States were employed by hospitals or corporate entities, up from 62% just five years earlier. 

Georgetown University’s Center on Health Insurance Reforms published those figures in a May 2026 analysis of the effects of vertical integration on consumers and clinicians.

Three federal bills have been introduced to strengthen antitrust enforcement against integrated insurer-provider organizations, according to Georgetown. 

Only one, the Break Up Big Medicine Act, introduced by Senator Elizabeth Warren (D-Mass.) with Senator Josh Hawley (R-Mo.) as co-sponsor, is bipartisan. That legislation would ban common ownership between insurers and physician practices. 

The other two, the Patients Over Profits Act and the Competition and Antitrust Law Enforcement Reform Act, are sponsored exclusively by Democrats.

Brookings traces the money inside each insurer’s corporate tree

Richard Frank, director of the Center on Health Policy at Brookings, and senior research assistant Samuel Peterson mapped the subsidiary networks and traced intercompany revenue flows.

UnitedHealth Group lists more than 2,000 subsidiaries, according to Brookings. In 2025, related entities paid Optum Health $63.6 billion, 63% of that division’s total revenue. 

The other major insurers follow similar playbooks:

CVS routes Aetna premiums through Caremark and Oak Street Health.

Elevance channels payments through CarelonRx.

Humana directs spending through CenterWell Senior Primary Care.

Standard plan documents do not disclose whether a Medicare Advantage plan’s insurer, physician network, and pharmacy benefit manager share one corporate parent.

What the Brookings subsidiary map means for plan shoppers

Georgetown’s Center on Health Insurance Reforms has called for greater transparency around ownership and affiliations in healthcare, research that can help enrollees determine whether their plan’s insurer also owns their primary care provider.

Brown’s research shows the financial consequences of that structure: increasing what taxpayers spend on Medicare Advantage while patient hospitalization and emergency room visit rates remain unchanged.

The Brookings subsidiary spreadsheet is the first publicly available dataset to trace those connections, and enrollees approaching the next open enrollment window can cross-reference their plan’s parent company against it before selecting or renewing coverage.

Related: Your health insurance may not protect your finances

Home Depot tries to copy major Costco perk

September 10, 2026 MMN Editor Filed Under: Uncategorized

If you’ve ever taken on a home renovation project, you probably know the feeling: You make a quick trip to Home Depot for one item, leave with a cart full of supplies, and realize you bought the wrong materials or didn’t buy enough, leading to a repeat trip.

For new homeowners, the experience can be even more familiar. A trip for paint, a replacement part, or a few tools can quickly become a regular ritual as one home project turns into another.

Now, Home Depot wants to make those visits a little more enjoyable.

The home improvement giant is expanding its Food Operations program, which brings local and regional food vendors to its stores. 

The program features food trucks and other mobile vendors offering breakfast, lunch, and dinner outside Home Depot locations around the country.

Home Depot says the initiative is designed to provide convenient food options while strengthening connections between its stores and their local communities. 

“Our mission is to provide local food options for our customers that enhance the shopping experience,” said Vice President of Merch Services Richard Goodrich. 

“Food vendors bring a sense of community and convenience to our stores while creating meaningful connections with customers.”

Home Depot takes a page out of Costco’s playbook

Home Depot clearly wants food to become part of the shopping experience. And it’s a concept that’s been proven to work, thanks to Costco’s famous food court.

Costco’s food court has become much more than a place to grab a cheap meal after shopping. 

The retailer’s famously low-priced food offerings reinforce its broader value proposition and give shoppers another reason to make the trip to a warehouse.

Related: Costco makes a delivery change members will love

That strategy matters because Costco isn’t simply selling pizza, hot dogs, and drinks. The food court has become one of the retailer’s most recognizable perks and a small but powerful part of its customer loyalty strategy.

Home Depot’s approach is a bit different.

The company isn’t building a standardized food court with a national menu. Instead, it’s bringing local food trucks and vendors to individual stores. 

That gives Home Depot something Costco doesn’t have to the same degree — a way to make individual stores feel more connected to their communities.

It also makes sense for the nature of a Home Depot visit. 

Customers can spend hours shopping for materials, especially during a renovation or major project. A food truck outside the store gives them an easy option to grab breakfast or lunch without making another stop.

Home Depot wants to provide convenient food options while strengthening connections between its stores and their local communities. Shutterstock

Home Depot has good reason to keep customers coming back

The timing of the food truck initiative also makes sense for Home Depot.

The retailer reported $47.9 billion in second-quarter fiscal 2026 sales, up 5.7% from a year earlier, while comparable sales increased 1.7%. U.S. comparable sales rose 1.3%. 

Home Depot said results exceeded its expectations and reaffirmed its full-year guidance.

But the company is still dealing with a challenging housing environment.

Home Depot executives said larger discretionary projects remain under pressure, while housing turnover has remained at historically low levels for several years. Higher mortgage rates have made consumers less willing or able to take on major renovation projects.

At the same time, Home Depot is dealing with rising fuel, energy, and other input costs. The company received $730 million in tariff refunds during the quarter, with $685 million reducing the cost of goods sold. 

But executives said those benefits would be offset by incremental cost pressures during the year. That makes initiatives designed to improve the shopping experience and drive sales crucial.

A low-effort strategy that could yield big results

Home Depot is clearly invested in boosting revenue. Food trucks fit neatly into that strategy because they add convenience without requiring Home Depot to make a major investment in restaurants.

“Home Depot adding food trucks makes sense because the strongest retailers are increasingly thinking beyond the transaction,” said RTM Nexus CEO Dominick Miserandino.

More Retail:

Costco sees major shift in member behavior

Retail chain shuts all locations as legal changes hit industry

Costco makes major investment in online shopping for members

“Costco’s food court works because it gives members another reason to linger, creates a little ritual around the shopping trip, and adds perceived value beyond the merchandise itself. Home Depot doesn’t need to become Costco, but anything that makes a high-consideration trip feel more convenient or enjoyable can strengthen the overall customer experience.”

If Costco’s food court can become a memorable part of the warehouse experience and reinforce the retailer’s value proposition, there’s a reasonable case that offering food can work for Home Depot, too.

For a customer who is already spending Saturday morning buying lumber, paint, and power tools, a good local breakfast or lunch waiting outside could be one more reason to make Home Depot the place they want to visit.

Maurie Backman owns shares of Costco.

Related: Walmart takes big step to make Sam’s Club memberships more valuable

Another travel agency shuts down after 19 years

September 10, 2026 MMN Editor Filed Under: Uncategorized

With different estimates pinning the total number of travel agencies registered in the United Kingdom in 2026 at between 16,887 to 17,519, the country surpasses many others on this front due to a historically strong travel culture and national interest in group tours and package holidays.

But amid the rise of online booking platforms and wider economic challenges brought on by the war in Iran, many have not survived the current headwinds. The United Kingdom has seen a particularly strong domino effect of travel agency collapses since the start of 2026.

Some British travel companies that either ended up in insolvency proceedings or ceased operations entirely in 2026 include Trav Expert, Groupia, Salamander Voyages, Travel Bespoke, Regen Central, Set Sail Cruises, Yourtravelshop.com, Ski Yodel, and TS Travels Group, among a number of others.

Barnes Worldwide Travel travel company shuts down operations

The most recent name to join that list is Liverpool-based Barnes Worldwide Travel Ltd. As was first reported by several British outlets, the travel company founded in 2007 ceased operations on Sept. 9.

Barnes Worldwide Travel booked tours to countries such as Greece, Cyprus, Türkiye and Egypt as well as New York and Las Vegas in the U.S. to local Liverpool travelers.

Related: Another low-cost airline is betting big on Colombia travel

“We are sorry to inform you that Barnes Worldwide Travel Ltd has ceased trading on 9 September 2026,” ABTA, the British organization representing travel agents and tour operators formerly known as Association of British Travel Agents, said in a statement.

The ABTA also offers consumer protection for packages purchased in the Unted Kingdom that include a flight but not for bookings that are only for accommodation.

Barnes Worldwide Travel was founded out of Liverpool in 2007.Image source: Shutterstock

What to do if you bought a recent trip with Barnes Worldwide Travel

As the company was not an independent tour operator but a travel agent selling other companies’ organized tours, the ABTA is encouraging travelers with booked trips to check directly with the tour provider to see whether the trip is still taking place and that they have a valid booking (in some cases over the years, travel agencies were shut down by regulators after it was discovered that they sold packages with invalid bookings).

“To ensure your holiday continues as planned, you will need to contact the credit control department of your tour operator or other principal travel business with whom you have a contract,” ABTA said further. “Your booking should continue as normal, and they will be your direct point of contact.”

More Travel News:

Airline to launch unusual new flight to Cayman Islands from the U.S.

There is a very cool Irish version of swimming pigs in The Bahamas

Unexpected country is most luxurious travel destination for 2026

Low-cost airline launches easier way to get to Sri Lanka

Some travel agencies filed for bankruptcy in 2026:

AVG Travels: The Melbourne-based travel agency selling cheap vacation packages to travelers in Australia and New Zealand sent more than 200 customers an email saying that the trips were canceled before entering bankruptcy in May 2026.

GoPlay Sports: In April 2026, the men’s basketball team of the University of Dallas was left without a planned trip to compete in the United Kingdom after Boston-based GoPlay Sports Tours LLC accepted two payments of $30,000 and then went unreachable.

Havantur: Havantur was forced to shut down its main European office in France at the beginning of 2026 after tourist numbers to the Caribbean country plummeted due to U.S. military actions in Venezuela and threats against the country.

Vegas Vacations and North America Destinations: Two travel agencies in the Canadian province of British Columbia, Vegas Vacations and North America Destinations, were shut down by regulators within a few days of each other in January 2026 after multiple travelers complained of buying trips and receiving invalid plane tickets and hotel bookings.

Related: 45-year-old tour company shuts down, cancels all trips

Small CPI surprise could trigger big Fed rate decision 

September 10, 2026 MMN Editor Filed Under: Uncategorized

Wall Street is about to get the one inflation number that could determine if the Federal Reserve raises interest rates next week.

With wholesale prices already showing renewed inflation pressure and crude oil prices climbing, the Sept. 11 August Consumer Price index has taken on importance for a divided Fed. 

Even a modest upside surprise in the August CPI could strengthen the case for a quarter-point rate hike when policymakers meet Sept. 15-16.

Economists and consensus forecasts expect the August CPI to show a bump in headline monthly inflation driven primarily by higher energy and gas prices.

Aptus Capital Advisors Portfolio Manager and Head of Fixed Income John Luke Tyner said the unexpected surge in the August jobs report puts additional pressure on the Fed’s price stability mandate.

“You typically don’t think about Fed decisions as binary outcomes but I wouldn’t be surprised if the fate of a September hike hinges upon the PPI and CPI prints,’’ Tyner told TheStreet in an email.

“With tariffs continuing to be in the conversation (Canada), energy prices higher, AI demand pretty much unaffected by higher rates, as well as data quirks from the government shutdown last year, it appears inflation pressures will not be fleeting soon.’’ 

The August CPI arrives one day after a hotter-than-expected August Producer Price Index report.

Producer prices rose 0.4% in August from July and 5.4% over the 12 months through August, adding to concerns that inflation pressures may be proving more persistent than Fed officials had expected.

Fed Governor Christopher Waller last week flagged both August prints as critical in the Federal Open Market Committee’s decision to hike rates or continue to hold.

Persistent sticky inflation could result in a 25-basis point hike in the Federal Funds Rate.

Then there’s Fed Chairman Kevin Warsh’s hawkish tone at last month’s Jackson Hole conference (“We have work to do”), during which he pledged the central bank would commit to taming inflation. 

“My opinion is Warsh does not want to hike and could be the swing vote on the decision,’’ Tyner said. 

“We will be interested in how markets react to the data and his decision next week. We are also interested in whether a skip in September would also mean a skip in October given Fed policy action around elections is unpopular. Bottom line: I do not envy his job,” he added.

Markets expect hot CPI report to trigger Fed rate hike

The CME Group FedWatch Tool, which gauges market expectations from federal-funds futures, shows traders increasingly betting on a rate hike at the Fed’s September meeting.

The odds rose to about 70% on Sept. 10, up from roughly 61% earlier in the week and below 50% late last month.

“This is the double-dog daring you. This is straight schoolyard,” BNY Investments Chief Economist Vincent Reinhart told The Wall Street Journal. 

Markets also are pricing in a growing likelihood that interest rates will be higher later this year.

The odds of a rate increase by the October meeting have climbed above 80%, while the probability of the rates being higher by December has risen even further.

As widely expected by investors, the European Central Bank voted Sept. 10 to raise three rates by 25 basis points to 2.5% from 2.25%, due to inflation concerns stemming from the Iran war. 

The ECB expects baseline inflation, excluding energy and food, to reach 2.5% in 2026, 2.6% in 2027 and 2.3% in 2028.

The Bank of Japan is also expected to raise interest rates due to the Iran war’s impact on gas and energy prices.

TheStreet

Fed’s dual mandate focuses on jobs, prices

The Fed’s dual mandate from Congress requires maximum employment and stable prices.

Lower interest rates support hiring but can fuel inflation. This risks fueling further inflation, potentially leading to an inflationary spiral.

Higher rates cool prices but can weaken the job market. This increases the cost of borrowing and further stifles economic activity.

The Sept. 4 blowout jobs report demonstrates the U.S. labor market is plowing through the economic uncertainty and financial jitters from the Iran war, despite higher gas and other energy prices. 

How Fed monetary policy affects you

The rate-setting FOMC voted 9-3 in July to hold the benchmark Federal Funds Rate target in a range of 3.5% to 3.75%. The three dissenters wanted to raise rates by 25 basis points because of inflation concerns.

Policymakers had cut rates by 25 basis points at its last three meetings of 2025 to shore up the softening labor market. 

Related: UBS doubles down on Fed rate-hike forecast for 2026

These “insurance” cuts stopped after the majority of policymakers decided the risk from higher prices was outweighing signs that the jobs market was stabilizing.

The funds rate is the interest rate at which banks lend balances at the Federal Reserve to other banks overnight. It sets the pace for short-term borrowing costs like credit cards, student loans and home equity loans.

Higher short-term interest rates impact mortgages, corporate credit

A change in the funds rate triggers moves in short-term borrowing costs, ranging from credit cards and student loans to home equity loans. 

Higher interest rates also increase the yield on fixed income and alter how equity markets value future corporate earnings.

The hotter-than-expected PPI report and climbing crude oil prices sent the benchmark 10-year Treasury yield surged to roughly 4.93%, near the critical 5.00% mark.

Yields across the board also reached their highest levels in three years. Market strategists note that if the 10-year crosses and holds above 5.00%, it will increase long-term borrowing costs for mortgages and corporate credit.

Related: Fed rate-hike threat heats up as August inflation data looms 

Dell enters the S&P 100 index after monstrous three-year rally

September 10, 2026 MMN Editor Filed Under: Uncategorized

Dell Technologies is about to sit at the same table as Apple, Microsoft, and Nvidia.

The company will join the S&P 100 index on Sept. 21, 2026, according to S&P Dow Jones Indices. 

Dell (DELL) stock has climbed roughly 700% over the past three years, which puts the hardware giant squarely in the same conversation as the market’s biggest names.

The same rebalancing also adds Palo Alto Networks, Arista Networks, and SanDisk, while removing Nike, Simon Property Group, and Colgate-Palmolive.

Why Dell stock is on an absolute tear

Dell’s surge is not random. It is tied directly to demand for AI infrastructure, the servers, storage, and networking gear that power artificial intelligence.

In fiscal Q2 of 2027 (ended in July), Dell reported revenue of $47 billion, an increase of 58% year over year. Meanwhile, earnings per share more than tripled year over year to $7.04. 

The Infrastructure Solutions Group, which includes AI servers, storage, and networking, posted revenue of $31.8 billion, up 89%. 

Related: Analyst resets Dell stock price target after earnings

Dell booked $60.9 billion in AI orders during Q2, a fresh record, and ended the period with a $95 billion AI server backlog.

Here is a quick snapshot of what pushed those numbers higher:

AI server orders topped $131.7 billion over the past 12 months.

Traditional server revenue jumped 122% as companies replace aging equipment.

Storage revenue grew 26%, its sixth straight quarter of demand growth above the market.

PC revenue in Dell’s Client Solutions Group rose 20%, its fastest pace in five years.

Operating expenses fell to about 8% of revenue, the lowest level in the company’s 42-year history.

CEO Michael Dell addressed the durability of that demand directly at the Goldman Sachs Communacopia and Technology Conference on Sept. 9. He pointed to a structural gap between AI chip supply and what companies need.

“All of the improvements in the models, particularly from basic LLMs to reasoning to agents, has occurred well within the timeframe required to build a new semiconductor fab,” Dell said. “You just have a structural shortage, probably worse in 2027 than in 2026 from everything that we see.”

Dell CEO Michael Dell is bullish on AI demand.Bloomberg / Getty Images

What the S&P 100 addition means for Dell stock

Getting added to the S&P 100 is not just a symbolic honor. The inclusion forces index funds and institutional portfolios that track the benchmark to buy shares, adding a fresh layer of short-term demand.

The S&P 100 is a subset of the broader S&P 500, made up of the 100 largest and most established companies by market value.

Membership signals that a stock has grown large and stable enough to be treated as a core holding rather than a speculative bet.

For Dell, the timing lines up with a business that is scaling fast.

The company raised its full-year revenue guidance by $25 billion, to $192 billion, and now expects AI server revenue to triple year over year to $74 billion. Full-year earnings per share guidance sits at $25.50, up roughly 150%.

Chief Financial Officer David Kennedy told analysts on the Sept. 1 earnings call that the company generated $8.1 billion in adjusted free cash flow during the quarter and returned an all-time record $4.3 billion to shareholders, including share buybacks at an average price of $401 per share.

What’s next for Dell stock price target 

Dell’s leadership sees a long runway ahead.

COO Jeff Clarke told investors the firm expects the AI infrastructure market to be worth more than a trillion dollars by 2030, with AI making up 75% of all data center demand by then.

Clarke also pointed to a massive installed base of aging equipment still waiting to be replaced.

More AI:

Nvidia just made a move Wall Street wasn’t ready for

Microsoft just took sides in AI policy fight

OpenAI just disclosed something genuinely alarming

Dell said 1.2 million servers in its customer base are still running on 14th generation hardware or older, a backlog of upgrades that should keep demand strong well beyond this year.

Michael Dell echoed that view, describing the company as still early in a broader shift where businesses reorganize around AI rather than simply buying faster computers.

“I would say we’re really at the very beginning of that in most companies,” Dell said. “They don’t know how to do it. It’s hard.”

Whether Dell stock keeps climbing at its recent pace is a separate question from the S&P 100 news. 

But the index addition confirms what the stock’s run already suggested. Wall Street now views Dell as core infrastructure for the AI economy. 

Out of the 21 analysts covering Dell stock, 14 recommend “Buy,” and seven recommend “Hold.” The average DELL stock price target is $595, above the current price of $535.

Related: Goldman Sachs resets Dell stock price target by $60

Popular women’s clothing chain closes 177 stores

September 10, 2026 MMN Editor Filed Under: Uncategorized

While I buy most of my clothes from Amazon, when I needed a new wardrobe for a video shoot, my wife and I went on a tour of local retailers.

Since I needed shirts that would hold up well in hot weather, we went to Target and Bass Pro Shops, and as much as I don’t like trying clothes on, I took advantage of the stores’ dressing rooms.

I’m not alone in wanting to try things on before I buy.

“The opportunity to try on clothes and test products is a major driver of store traffic,with 52% of consumers surveyed saying they go to stores instead of shopping online because of this. References to trying on/testing products surged 32% YoY on average at retailers and were up 58% at beauty retailers,” according to a Chatmeter report published last year.

People, me included, like seeing what they’re buying before committing to a purchase.

“When asked about their favorite part of a recent store visit, 21% mentioned trying aproduct while 25% mentioned seeing a product in real life,” the data showed.

Once I picked out the shirt I liked, I bought a few from the store, went back a week later to buy more, but then ordered more colors online. And since we no longer live near Bass Pro Shops, I’ll likely become an online customer.

That’s the problem facing retailers like Torrid. Physical stores deliver a better experience, because they introduce customers to merchandise and allow them to leave the store with their size. But if customers buy in-store once and then order online, that dramatically changes the economics for brick-and-mortar locations.

That’s at least part of the struggle for Torrid, a women’s specialty retailer featuring plus-sized clothes, which has closed 20% of its stores.

Torrid has shrunk its store base

In June 2025, Torrid shared a plan to close around 180 underperforming stores from its fleet of just over 620.

Torrid CEO Lisa Harper shared her company’s plan in its first-quarter earnings release.

“Digital continues to be our customers’ preferred channel, now approaching 70% of total demand. We’re accelerating our transformation to a more digitally-led business, which includes optimizing our retail footprint,” she said.

Harper then got specific about the planned shutdowns.

“We now plan to close up to 180 underperforming stores this year — allowing us to reduce fixed costs and reinvest in areas that drive long-term growth, including customer acquisition and omnichannel enhancements,” she added.

More Retail:

Home Depot is making a big bet on cautious consumers

Another state just banned a controversial retail pricing practice

JPMorgan just flagged a slow-build food crisis

Those closures have rolled out slowly, but are now mostly complete, and the company’s challenge is keeping the sales those stores generated.

“As I mentioned on our Q1 call, we substantially completed our store optimization program. To date, we’ve closed an additional six structurally unproductive locations, bringing the total to 177 closures since we initiated the program. Customer retention through this transition has remained strong, with our marketing efforts successfully redirecting traffic both online and to nearby stores,” she said during the company’s second-quarter earnings call.

Torrid has closed about 20% of its retail stores.Shutterstock

Torrid has seen mixed results

Harper tried to sell Torrid’s Q2 results as the company delivering on its plans.

“Our second quarter results were in line with guidance. Sales trends improved meaningfully as the quarter progressed, with July marking a clear inflection point. This improvement reflects early traction from our customer growth strategy and the merchandising course corrections we have made,” she said in a press release.

The results showed that while sales were down, margins and profits improved, suggesting the store closures are helping the company’s bottom line.

Net sales decreased 11.8% to $231.7 million compared to $262.8 million for the second quarter of last year.

Comparable sales decreased 6.3% in the second quarter.

Gross profit margin increased to 38.7% compared to 35.6% in the second quarter of last year.

Gross profit margin, excluding the benefit of tariff refunds received, was 33.9%

Net income was up to $5.2 million, or $0.05 per share, compared to net income of $1.6 million, or $0.02 per share, in the second quarter of last year.

“Torrid shedding a huge chunk of its stores is a brutal, necessary acknowledgment that physical stores were becoming a drag on their bottom line. When over 70% of your sales are happening online, maintaining hundreds of low-productivity mall leases is just burning cash,” RTM Nexus CEO Dominick Miserandino told TheStreet.

He thinks the chain matches the needs of its customer base.

“These are Plus-size specialty shops which rely heavily on deep customer loyalty, and Torrid already retains the majority of those shoppers digitally whenever a local store closes. Trimming underperforming physical locations lets them cut massive real estate overhead and pour capital back into e-commerce, digital marketing, and product,” he added.

Torrid serves a growing market

Torrid describes itself as a direct-to-consumer apparel, intimates, and accessories brand in North America for women sizes 10 to 30.

The plus-size women’s clothing market has been steadily growing.

“Plus-size clothing for women market revenue was valued at $23.6 billion in 2024 and is estimated to reach $37.4 billion by 2033, growing at a CAGR of 6.5% from 2026 to 2033,” according to data from Verified Market Reports.

CAGR, or compound annual growth rate, shows that the market will be expanding.

The report also shared some other key facts about the growing women’s plus-sized fashion market.

E‑commerce channels are growing at the fastest pace, comprising more than 60% of sales and outpacing traditional brick‑and‑mortar outlets.

North America currently dominates the market, accounting for more than 35% of total revenue, with Europe and Asia Pacific following closely.

The shift to online sales has been noticeable, even as more traditional retailers, including Target, have broadened their in-store selections to be more size-inclusive.

Over a year ago, when the shutdowns were announced, GlobalData Managing Director Neil Saunders shared his support for the chain’s actions.

“The closures are largely sensible, since they will free up capital to invest in things like better marketing and product development,” Saunders told NewJersey.com. “Money will also go into stores that are showing potential.”

ALSO READ: Costco fixed the one thing members hated about shopping there

Starbucks changes iconic recipe, angering customers again  

September 10, 2026 MMN Editor Filed Under: Uncategorized

Over the last few years, Starbucks made several operational moves that frustrated its core customers. To cut operational delays and improve profit margins, the chain has repeatedly overhauled its offerings, pricing, and rewards program. 

About three years ago, Starbucks increased the number of loyalty “stars” required to redeem free drinks, food, and merchandise, and it also angered iced-drink fans by introducing a mandatory $1 charge for customers who ordered Refreshers with “no water,” according to Entrepreneur.

In 2023 and 2024, Starbucks spent heavily to promote olive-oil-infused coffee, a pet project of former CEO Howard Schultz. The drinks sparked viral mockery and widespread complaints about stomach issues before the company finally abandoned the lineup in late 2024 to simplify its menu, reported CNN. 

Earlier this year, Starbucks made major menu cuts, under CEO Brian Niccol’s “Back to Starbucks” turnaround strategy, slashing its menu by 25% to 30%. The chain cut 13 drinks to reduce waste and speed up drink preparation for baristas, reported TheStreet. 

Now, the chain’s latest menu change has once again frustrated some of its loyal customers, and they are calling headquarters to complain. 

Starbucks reinvents iconic chai recipe 

In March 2026, Starbucks revealed a change to its chai latte recipe, saying it was “reinventing an icon.”

The chain said the overhaul will make it a less sweet chai base to allow customers to customize the beverage to their own preference. 

“The updated chai recipe allows spices like cardamom, cinnamon and ginger to take center stage while giving customers more control over their preferred sweetness level by adjusting the number of pumps. Or they can adjust the flavor by swapping classic syrup for a flavored one. Vanilla, for example, will dial up the spicy notes. The beverage is also delicious unsweetened,” Starbuck stated. 

The change, however, didn’t sit well with some customers. 

Starbucks tweaked its iconic chai recipe, angering some customers.NicolasMcComber / Getty Images

Starbucks’ chai change angers some customers 

A number of customers took to social media, or called corporate and signed petitions to reverse what they are calling the “Great Chai Incident of 2026,” highlighted The Wall Street Journal. 

Ricki Fairley, a 70-year-old customer, sent a formal complaint to Starbucks’ CEO demanding that the company “turn this unnecessary mess around.” 

Another loyal customer, Adam Benson, mourned the loss of his usual order, stating, “I had found my drink, my happy place. Now it’s been taken away.”

Desperate fans have even started swapping recipes on platforms like Reddit to figure out how to replicate the original taste. Baristas are doing their best to help, but finding the exact match is proving difficult. One Reddit user shared their best workaround, posting, “The closest I’ve been able to get to bringing its sparkle back has been no classic, half vanilla, half cinnamon dolce.”

Facing backlash, Starbucks tweaked the recipe again about a month later, removing water from the hot chai to make it creamier and spicier. Still, for many loyal tea drinkers, the magic is gone, and they have resorted to making it at home. 

A number of customers suspect the change aimed only to reduce costs, since adding flavors such as vanilla or brown sugar costs an extra 80 cents. 

“They may have cut costs but they’ve lost me as a customer. For the past 20 years I’ve gotten a Starbucks chai almost every single day, and I’ve been back 3 times now since March,” wrote one Reddit user. 

Not everyone is displeased with the change, however. 

Some customers actually like the new chai better 

In matters of taste, there can be no disputes, the old saying goes, and it holds true in this case. 

In another Reddit thread (though one that got significantly fewer reactions), a few customers shared that they prefer the new chai. 

“All the customers I’ve talked to today love the change,” the Reddit user who started the thread shared. 

Related: 29-year-old casual dining chain closes 4 locations after acquisition

What’s particularly interesting is the comment posted by a user identifying as a Starbucks barista who said that what seems to be happening is that customers who didn’t like the chai before now think it’s good, while those who liked it previously don’t like it now. 

The user added that there’s “definitely a higher percentage of people that dislike it.” 

It appears that this latest Starbucks change has managed to gain some new chai fans, but at the same time, it has lost a number of old ones.

Why product changes trigger deep customer anger

When an iconic brand changes a popular product, it can disrupt a daily emotional ritual, and the effect on customers can be overwhelming. Market research shows that consumers don’t buy a beverage just for its ingredients. They buy it for psychological comfort and predictability. 

When that changes without warning, customers may register it as a betrayal.

“Brands are key in building customer-brand relationships, yet organisations change their product lines by reformulating or discontinuing brands. This results in negative customer emotions, including pain and grief,” according to a study on product changes published in the Journal of Business Research. 

In 1985, Coca-Cola discontinued its original formula and introduced a sweeter “New Coke” after blind taste tests showed consumers preferred the new flavor over both the original recipe and Pepsi. 

However, the company drastically underestimated the emotional attachment its loyal customers had to the classic beverage. Following severe public backlash, Coca-Cola brought back the original formula just 79 days later, according to History.com.

Coca-Cola went back to its original recipe to retain its customers. Whether Starbucks follows suit may depend on how much the chai backlash ends up hurting its bottom line. 

Related: Fast-food chain quietly exits an entire state after 50 years

Novartis stock in hot water after another key failure

September 10, 2026 MMN Editor Filed Under: Uncategorized

Novartis (NVS) had a disappointing Tuesday, Sept. 8. Shares dropped nearly 14% on one of the company’s worst trading days on record.

The sell-off followed news that a closely watched experimental drug failed its main goal in a late-stage trial. The timing was bad, since the company was already dealing with a trial failure from days earlier.

Novartis is one of the largest drugmakers in the world. It develops and sells prescription medicines across cancer, heart disease, immunology, and neuroscience.

Because the company earns most of its money from a handful of popular branded drugs, its business model depends heavily on new drugs reaching the market. So when a major drug trial fails, investors pay attention.

Why the del-desiran trial failure hit Novartis stock so hard

The drug in question is del-desiran, an experimental treatment for myotonic dystrophy type 1 (DM1).

DM1 is a genetic disease that causes progressive muscle stiffness and weakness. There are no approved treatments for it.

Novartis said its Phase III HARBOR study found no real improvement over patients who got no active treatment. 

The trial’s primary test was on video hand opening time, which tracks how well patients can relax their hand muscles.

More Pharma Stocks:

Eli Lilly raises the stakes in $2.88 billion autoimmune buyout

BofA makes bullish call on newly public biotech stock

BofA biotech scorecard: two buys and odd one out

Del-desiran was the main asset from the company’s roughly $12 billion purchase deal with Avidity Biosciences completed in February 2026, according to Novartis. 

The drug had won FDA Fast Track and Breakthrough Therapy status, so hopes for approval ran high.

Although the primary test failed, Novartis noted some encouraging signs in secondary measures, along with a clean safety record. 

The company plans to review the full data before it decides what comes next.

Novartis shares fell nearly 14% on Sept. 8, 2026, after a second late-stage drug trial failure in days.SOPA Images / Getty Images

A rough stretch for the Novartis pipeline

This was the second late-stage failure in a matter of days.

Just before it, Novartis’s heart drug Pelacarsen failed to reduce the risk of major cardiac events in a large trial, Bloomberg reported. 

Analysts had estimated peak sales of roughly $4 billion to $6 billion for that drug, which the company developed with Ionis Pharmaceuticals.

Related: Morgan Stanley uncovers major Bristol Myers stock signals

Novartis also recently paused several trials in its experimental CAR-T cancer therapy program after patient deaths. 

Three setbacks in quick succession is a lot for any drugmaker to absorb, and shareholders are recalculating what the pipeline is really worth.

What Novartis investors should weigh now

Analysts at Jefferies and Barclays are openly questioning whether Novartis can hit its target of 5% to 6% annual sales growth through 2030, Reuters reported.

That target looks harder to reach with key patents expiring soon. The company’s top-selling heart drug, Entresto, has already begun to lose exclusivity, and more blockbuster drugs are set to follow.

Here is what shareholders should keep in mind.

Key risks and takeaways for Novartis stock

More deals may be coming. Because internal research has stalled, Novartis may likely buy more biotech firms at high prices to refill its pipeline, which can dilute existing shareholders.

The premium is fading. Investors treated Novartis as a stable giant, and that reputation is now being repriced lower.

The dividend is still solid. The stock offers a yield of about 3.4%, which is a cushion for patient holders.

Volatility is real. Big pharma stocks can swing hard around trial results, so position sizing matters.

Novartis remains profitable and pays a healthy dividend.

But the steady reputation that justified its premium price is under pressure, and rebuilding trust in the pipeline will take time and probably more expensive acquisitions.

For now, cautious investors may want to watch how the company’s management handles the full del-desiran data before they make any big moves.

Related: Novo Nordisk CEO resets expectations for Wegovy’s explosive growth

UBS sets $730 target on a stock it just stopped doubting

September 10, 2026 MMN Editor Filed Under: Uncategorized

Wall Street analysts almost never announce that they were wrong. They reprice instead.

That habit is worth keeping in mind whenever a bank moves a stock two full rating notches before the opening bell, because the useful information is usually buried underneath the rating, not in it.

Consider the corner of the market that has spent three years absorbing punishment for a sin it stopped committing a while ago.

Life sciences tools companies sell the instruments, reagents, and outsourced lab services that drug developers can’t operate without. They boomed through the Covid pandemic, then fell hard when biotech funding dried up, academic budgets froze, and Chinese demand went quiet.

Earnings, though, never actually broke. They just stopped getting paid for. Revenue continued compounding, margins kept widening, and the multiple kept shrinking anyway.

That gap between profits and price is the setup behind one of the more aggressive analyst calls of the week, and behind a price target that landed a long way from where the rest of the Street is standing.

Thermo Fisher Scientific (TMO), the largest company in the group, was upgraded to Buy from Neutral at UBS on Sept. 9, and the firm boosted its price target on the shares to $730 from $540, according to 24/7 Wall St.

That is roughly $190 added to a number the firm had been sitting on. Banks do not usually move that far in one motion, and the reason this one did has almost nothing to do with the last earnings report.

Why life sciences tools stocks stopped working

Thermo Fisher’s earnings per share has grown about 7% a year over the past three years while the share price has gone essentially nowhere, according to Simply Wall St. That is a de-rating, not a deterioration.

The cause, when I went back through the demand picture, was that every customer group went cold at once.

Pharma and biotech, which account for roughly 60% of Thermo Fisher’s revenue, cut discretionary spending. Academic and government labs sat on frozen budgets. China, once the group’s growth engine, contracted for several straight quarters.

Related: UBS revamps S&P 500 target for rest of 2026

Instrument purchases are the first line item a lab defers and the last one it restores. That turned a health care name into something that trades like an early-cycle industrial, which is exactly what happened to the multiple.

The wider market spent the same stretch paying up for anything with an artificial intelligence (AI) attachment, a rotation that left slower compounders stranded. 

UBS upgraded Thermo Fisher Scientific to Buy and lifted its TMO price target to $730 from $540.Boston Globe / Getty Images

What UBS actually changed on Thermo Fisher

The upgrade did not come out of the second-quarter print. It came out of the 2027 model.

Thermo Fisher is positioned for “a durable return to 5%-6%-plus organic growth in 2027,” the firm told investors in a research note, reported TheFly.

More Wall Street:

SpaceX investors get bold Wall Street price target for 2027 year-end

Anthropic sends clear message to Wall Street ahead of IPO

Bank of America’s unique take on Apple stock as Ternus takes reins

Alongside that growth call, UBS projects operating margin expansion of at least 50 to 70 basis points and double-digit earnings per share growth, according to Investing.com.

The drivers it lists are better pharma and biotech funding, reshoring investment, sustained bioprocessing demand, AI-driven gains in research and development returns, market share gains, and stabilization in China and in academic and government spending.

Here is where the number sits relative to everyone else’s:

UBS raised its target to $730 from $540 while moving to Buy from Neutral, according to 24/7 Wall St.

CLSA analyst Michael Luo started coverage at Outperform with a $748 target on Sept. 3, above the UBS number, according to StockAnalysis.

The average 12-month target across the 29 analysts covering the stock is about $638, according to StockAnalysis.

When I lined the $730 up against that $638 average, the spread was the tell. UBS is not nudging a model. It is sitting roughly 14% above where the rest of the Street has settled, and it got there in one jump rather than through the usual quarterly drift.

The analyst handoff hiding inside the upgrade

Most of the coverage treated this as a bank changing its mind. That is not quite what happened.

The rating change arrived as UBS assumed coverage of the stock with a new analyst, according to Investing.com.

That distinction matters more than it sounds. A coverage transfer means the person who defended the Neutral rating is no longer the person writing the note. Incoming analysts routinely reset a predecessor’s stance in their first publication, and those resets tend to be large precisely because they are catching up all at once, instead of adjusting a quarter at a time.

My read is that UBS is not calling a bottom in laboratory demand. It is calling the end of a de-rating, and it is doing it through a fresh set of eyes. Anyone treating this as a firm publicly reversing itself is reading the wrong signal.

What a 2027 growth reset would mean for the stock

The recovery evidence is already on the tape, which is part of why the target moved so far.

Second-quarter revenue grew 10% to $11.99 billion, including 5% organic growth. Adjusted operating margin expanded 90 basis points to 22.8%, and adjusted earnings per share rose 13% to $6.03, according to the company’s second-quarter results. Chairman and CEO Marc Casper cited “outstanding performance in the second quarter” in that release.

Full-year guidance went to $47.4 billion to $48.1 billion in revenue, with adjusted earnings per share of $24.93 to $25.33.

The detail that should interest anyone modeling 2027 is geographic. China grew in the low single digits for the first time in several quarters, and academic and government spending returned to growth, reported GenomeWeb. Management stopped short of calling the academic recovery durable.

Two things have to hold for the UBS math to work:

Pharma and biotech budgets need to keep loosening into next year.

That academic thaw must prove structural rather than seasonal.

For a reader with a retirement account rather than a trading screen, the practical version is simpler. This is the kind of position that quietly underperformed for three years while its profits did not, and a growth reset in 2027 would close that gap without management doing anything heroic.

Shares traded near $606 on Sept. 9, putting the UBS target about 20% above the market. None of the 2027 thesis becomes testable until well into next year, which makes the next four quarters a referendum on whether the funding thaw is real.

That, not the target, is the number worth watching.

Related: UBS sends investors strong message about the economy

Jensen Huang just answered Michael Burry’s Nvidia bear case

September 10, 2026 MMN Editor Filed Under: Uncategorized

Nvidia CEO Jensen Huang posted GPU rental data on X on X (the former Twitter) on Sept. 8 and tagged it directly at investors who think the AI chip boom is built on shaky accounting.

Short seller Jim Chanos saw it and fired back within hours.

The post touched on one of the most-watched debates in AI investing right now. Michael Burry has a short position in Nvidia. He thinks the companies buying Nvidia chips are booking profits they have not actually earned.

Huang’s Sept. 8 post was the latest round of his pushback against that view.

Burry doubts profits of companies buying Nvidia chips: why it matters

Burry called the 2008 housing crash. He disclosed a Nvidia short through Scion Asset Management earlier this year. His argument is that cloud companies are writing Nvidia GPUs off too slowly on their books, which inflates their annual profits, according to CNBC.

Google, Microsoft, and Oracle all estimate that their AI chips last about six years. Burry said two to three years is closer to the truth, given how quickly Nvidia ships new architectures. He estimated the cloud providers are understating their depreciation costs by around $176 billion between 2026 and 2028, Benzinga reported.

More Nvidia:

Nvidia just made a move Wall Street wasn’t ready for

Nvidia just locked down deal that changes AI race

Nvidia stock is doing something it hasn’t done in years

Meta put some real numbers on this in early 2025. The company said extending the useful life of certain servers to 5.5 years cut its depreciation expense by about $2.9 billion that year.

Burry said Google, Microsoft, and Oracle are doing the same kind of accounting across far larger GPU fleets. He has been making this case publicly since late 2025. His firm has not given a public interview explaining the trade.

The depreciation argument is the clearest version of the Nvidia short that has surfaced from Burry’s filings and social media posts.

Huang posted rental prices for Nvidia chips: how Chanos responded

Huang shared a post from financial market platform Ornn Exchange on Sept. 8. Ornn reported that rental prices for Nvidia H100 chips jumped 22% in one month to $3.28 per hour. The H100 launched in 2022, so it’s three years old and more expensive to rent now than it was last month.

In an Aug. 13 post on X, Huang highlighted that CoreWeave signed a contract to rent Nvidia A100 GPUs through 2029. The A100 launched in May 2020. That is nine years of useful life on a chip that Burry’s model said should be economically done.

CoreWeave went public earlier this year. It has contracts covering nearly triple the GPU capacity it currently has online. Signing a nine-year deal on six-year-old hardware is the kind of data point Huang wanted investors to see.

“The mighty A100 fleet are mission-capable from 2020 through 2029,” Huang said in the Aug. 13 post. “NVIDIA compute is fungible, durable, and highly rentable. It is a productive, revenue-generating asset.”

Chanos replied to Huang’s Sept. 8 post. “Then why not rent them out yourself? Or simply keep raising prices?” Chanos wrote.

He later said his point was aimed at companies buying Nvidia chips to rent them out, not Nvidia itself. Chanos is short on data-center and neocloud companies. He has called the GPU rental business a commodity.

Michael Burry called the 2008 housing crash. He disclosed a Nvidia short through Scion Asset Management earlier this year.Bloomberg / Getty Images

What the GPU market data show

CoreWeave CEO Mike Intrator spoke about chip pricing on the company’s second-quarter earnings call. A batch of H100 GPUs that came off an expired contract was immediately rebooked at 95% of the original price.

“All of the data points that I’m getting are telling me that the infrastructure retains value,” Intrator told CNBC.

Silicon Data, which tracks GPU residual values, put the resale value of six-year-old A100 chips at around $5,000 as of September, Benzinga reported. The firm also said A100 pricing stopped falling in late 2025. H100 and B200 chips have more value in 2026 as rental rates have risen.

Chanos has previously warned of what he called a “depreciation time bomb” at companies such as CoreWeave and Oracle. He has argued that chips can become economically obsolete within three to four years, even while still running, according to Benzinga.

Where this stands right now

Burry is still short Nvidia. Chanos is still short neocloud and data center stocks. Huang is still posting chip rental data on X.

A100 chips from 2020 are renting through 2029. H100 chips from 2022 are up 22% in rental price in a month. Rebooked H100 contracts are coming in at 95% of the original rate.

Nvidia shares have pulled back from their 2024 highs but remain one of the most widely held stocks among institutional investors. The company has been backing large AI infrastructure deals and positioned its GPUs as long-lived financial assets, not just chips.

That framing is exactly what Burry and Chanos are pushing back against.

Burry was years early on the housing crash. He was right about the structure of that problem but wrong on the timing for a long time. He could be in the same position here.

Nvidia has not addressed his depreciation argument in detail beyond Huang’s X posts. The monthly GPU rental numbers are the closest thing to a live scorecard on this debate.

CoreWeave’s next earnings call and Nvidia’s own quarterly results will add more data points to a trade that both sides are watching closely.

Related: Jim Cramer has strong message for Nvidia, Broadcom investors

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 49
  • Page 50
  • Page 51
  • Page 52
  • Page 53
  • Interim pages omitted …
  • Page 106
  • Go to Next Page »

© 2026 Mad Mad News™ · OGGHY Media™ Live Above the Madness™ Independent news, signals, and analysis. Atlanta, Georgia